An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors

被引:20
|
作者
Xie, Huiding [1 ,2 ,3 ]
Li, Yupeng [2 ,3 ]
Yu, Fang [2 ,3 ]
Xie, Xiaoguang [1 ]
Qiu, Kaixiong [2 ,3 ]
Fu, Jijun [2 ,3 ]
机构
[1] Yunnan Univ, Dept Chem, Kunming 650091, Peoples R China
[2] Kunming Med Univ, Dept Chem, Sch Pharmaceut Sci, Kunming 650500, Peoples R China
[3] Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Kunming 650500, Peoples R China
基金
中国国家自然科学基金;
关键词
imidazopyridine; B-Raf kinase; molecular docking; molecular dynamic simulation; THERAPEUTIC TARGET; CANCER; PROTEINS; MELANOMA; BRAF;
D O I
10.3390/ijms161126026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the recent cancer treatment, B-Raf kinase is one of key targets. Nowadays, a group of imidazopyridines as B-Raf kinase inhibitors have been reported. In order to investigate the interaction between this group of inhibitors and B-Raf kinase, molecular docking, molecular dynamic (MD) simulation and binding free energy (G(bind)) calculation were performed in this work. Molecular docking was carried out to identify the key residues in the binding site, and MD simulations were performed to determine the detail binding mode. The results obtained from MD simulation reveal that the binding site is stable during the MD simulations, and some hydrogen bonds (H-bonds) in MD simulations are different from H-bonds in the docking mode. Based on the obtained MD trajectories, G(bind) was computed by using Molecular Mechanics Generalized Born Surface Area (MM-GBSA), and the obtained energies are consistent with the activities. An energetic analysis reveals that both electrostatic and van der Waals contributions are important to G(bind), and the unfavorable polar solvation contribution results in the instability of the inhibitor with the lowest activity. These results are expected to understand the binding between B-Raf and imidazopyridines and provide some useful information to design potential B-Raf inhibitors.
引用
收藏
页码:27350 / 27361
页数:12
相关论文
共 50 条
  • [1] Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants
    Scaini, Maria Chiara
    Piccin, Luisa
    Bassani, Davide
    Scapinello, Antonio
    Pellegrini, Stefania
    Poggiana, Cristina
    Catoni, Cristina
    Tonello, Debora
    Pigozzo, Jacopo
    Dall'Olmo, Luigi
    Rosato, Antonio
    Moro, Stefano
    Chiarion-Sileni, Vanna
    Menin, Chiara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [2] B-Raf kinase inhibitors for cancer treatment
    Li, Nanxin
    Batt, David
    Warmuth, Markus
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (06) : 452 - 456
  • [3] Development of potent inhibitors of B-Raf kinase
    Wei, Jianmei
    Wolin, Ronald
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [4] Development of selective B-RAF kinase inhibitors
    Jones, John H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [5] Accurate Activity Predictions of B-Raf Type II Inhibitors via Molecular Docking and QSAR Methods
    Liu Hai-Chun
    Lu Shuai
    Ran Ting
    Zhang Yan-Min
    Xu Jin-Xing
    Xiong Xiao
    Xu An-Yang
    Lu Tao
    Chen Ya-Dong
    ACTA PHYSICO-CHIMICA SINICA, 2015, 31 (11) : 2191 - 2206
  • [6] Molecular Docking and 3D-QSAR Studies on a Series of Fused Heterocyclic Amides as B-Raf Inhibitors
    王路
    张艳敏
    卢帅
    陈亚东
    陆涛
    刘海春
    结构化学, 2017, 36 (09) : 1568 - 1585
  • [7] Molecular Docking and 3D-QSAR Studies on a Series of Fused Heterocyclic Amides as B-Raf Inhibitors
    Wang Lu
    Zhang Yan-Min
    Lu Shuai
    Chen Ya-Dong
    Lu Tao
    Liu Hai-Chun
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2017, 36 (09) : 1568 - 1585
  • [8] Dual binding site inhibitors of B-RAF kinase
    Wolin, Ronald L.
    Bembenek, Scott D.
    Wei, Jianmei
    Crawford, Shelby
    Lundeen, Katherine
    Brunmark, Anders
    Karlsson, Lars
    Edwards, James P.
    Blevitt, Jonathan M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2825 - 2829
  • [9] Management of metastatic melanoma: B-raf kinase inhibitors
    McCormack, C.
    McArthur, G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2010, 51 : A3 - A3
  • [10] Mutant B-Raf Kinase Inhibitors as Anticancer Agents
    Asati, Vivek
    Bharti, Sanjay K.
    Mahapatra, Debarshi K.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (12) : 1558 - 1575